Showing items 1 - 13 of 13

Your selections:

Oral administration of a 2-aminopyrimidine robenidine analogue (NCL195) significantly reduces Staphylococcus aureus infection and reduces Escherichia coli infection in combination with sub-inhibitory colistin concentrations in a bioluminescent mouse model

Antigiardial Activity of Novel Guanidine Compounds

Impact of a Novel Anticoccidial Analogue on Systemic Staphylococcus aureus Infection in a Bioluminescent Mouse Model

In Vitro Activity of Robenidine Analogues NCL259 and NCL265 against Gram-Negative Pathogens

Comparison of two transmission electron microscopy methods to visualize drug-induced alterations of gram-negative bacterial morphology

In vitro synergistic activity of NCL195 in combination with colistin against Gram-negative bacterial pathogens

In vitro activity of robenidine analog NCL195 in combination with outer membrane permeabilizers against gram-negative bacterial pathogens and impact on systemic gram-positive bacterial infection in mice

Aminoguanidines: new leads for treatment of Giardia duodenalis infection

Discovery of 4,6-bis(2-((E)-benzylidene)hydrazinyl)pyrimidin-2-amine with antibiotic activity

In vitro antimicrobial activity of Robenidine, Ethylenediaminetetraacetic acid and Polymyxin B Nonapeptide against important human and veterinary pathogens

Gram-Positive and Gram-Negative Antibiotic Activity of Asymmetric and Monomeric Robenidine Analogues

Evaluation of robenidine analog NCL195 as a novel broad-spectrum antibacterial agent

Robenidine analogues as gram-positive antibacterial agents

  • 1
  • Disclaimer
  • Privacy
  • Copyright
  • Contact
  • Deposit